172@29@16@22!~!172@29@0@53!~!|company-article|aurobindopharma|news|AP!~!www|moneycontrol|com!~!|stocks|company_info|stock_news.php!~!is_mobile=false
Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Aurobindo Pharma

Aurobindo Pharma

BSE: 524804|NSE: AUROPHARMA|ISIN: INE406A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 30, 16:00
772.75
4 (0.52%)
VOLUME 100,674
LIVE
NSE
Oct 30, 15:59
772.65
5 (0.65%)
VOLUME 2,036,809
News on Aurobindo Pharma
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Aurobindo Pharma; target of Rs 985: Motilal Oswal

1.19 pm | 28 Oct 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26...

Buy Aurobindo Pharma; target of Rs 1025: ICICI Direct

2.00 pm | 27 Oct 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26...

Aurobindo Pharma share price rises 4% as subsidiary sells business assets

10.34 am | 26 Oct 2020 |  Source: Moneycontrol.com

Jefferies served as the sole financial adviser and Sullivan & Cromwell LLP acted as legal counsel to Aurobindo....

Market to remain volatile till US elections, these 18 stocks can give 10-37% return

2.00 pm | 07 Oct 2020 |  Source: Moneycontrol.com

Long-term investors should pick their favourite mid and smallcap shares gradually over the next few months, experts say....

Buy Aurobindo Pharma; target of Rs 1030: Motilal Oswal

11.22 pm | 28 Sep 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1030 in its research report dated September...

Buy Aurobindo Pharma; target of Rs 975: Sharekhan

12.14 pm | 23 Sep 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 975 in its research report dated September ...

Aurobindo Pharma: Shot in the arm for Covid vaccine development programme

9.40 am | 16 Sep 2020 |  Source: Moneycontrol.com

Vaccine capacity creation puts Aurobindo in the league of Serum Institute of India and Cadila in the race for a Covid drug...

Buy Aurobindo Pharma; target of Rs 1027: KR Choksey

11.07 am | 19 Aug 2020 |  Source: Moneycontrol.com

KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1027 in its research report dated August 1...

Buy Aurobindo Pharma; target of Rs 1000: Emkay Global Financial

5.06 pm | 17 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report da...

Hold Aurobindo Pharma; target of Rs 838: Prabhudas Lilladher

9.08 am | 16 Aug 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated August 13, 2020....

Hold Aurobindo Pharma; target of Rs 975: Sharekhan

7.21 am | 16 Aug 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 975 in its research report dated August 13, 2020....

Buy Aurobindo Pharma; target of Rs 1055: Motilal Oswal

7.20 am | 16 Aug 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1055 in its research report dated August 13...

Buy Aurobindo Pharma; target of Rs 835: Emkay Global Financial

8.50 pm | 07 Jun 2020 |  Source: Moneycontrol.com

Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dat...

Buy Aurobindo Pharma; target of Rs 880: Motilal Oswal

8.36 pm | 07 Jun 2020 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 880 in its research report dated June 0...

Hold Aurobindo Pharma target of Rs 840: Sharekhan

8.35 pm | 07 Jun 2020 |  Source: Moneycontrol.com

Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 840 in its research report dated June 04, 2020....

Accumulate Aurobindo Pharma; target of Rs 838: Prabhudas Lilladher

8.26 pm | 07 Jun 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated June 05, 2020....

Buy Aurobindo Pharma; target of Rs 835: HDFC Securities

8.18 pm | 07 Jun 2020 |  Source: Moneycontrol.com

HDFC Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June...

Buy Aurobindo Pharma; target of Rs 920: ICICI Direct

8.04 pm | 07 Jun 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 920 in its research report dated May 05,...

Aurobindo Pharma likely to become debt-free by FY22: Key highlights of concall

4.26 pm | 06 Jun 2020 |  Source: Moneycontrol.com

Aurobindo Pharma's R&D expense for FY21 is expected to be at 5.5% of sales as the clinical trials for Biosimilars & differentiated products starts...

Buy Aurobindo Pharma; target of Rs 870: ICICI Securities

11.56 am | 05 Jun 2020 |  Source: Moneycontrol.com

ICICI Securities is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 870 in its research report dated Jun...

1 2
Quick Links for Aurobindo Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.